Abortion : Termination of Early Pregnancy with RU-486 (Mifepristone).

Describes background of FDA approval and conditions of use for the abortion drug mifepristone, also known as RU-486, and legislative issues that may include restrictions on program funding and drug use. Considers FDA approval of the drug in 2000 and potential impact of RU-486 use.

Bibliographic Details
Corporate Authors:	Library of Congress. Congressional Research Service, ProQuest (Firm)
Format:	eBook
Language:	English
Published:	[Place of publication not identified] : [publisher not identified], 2001.
Series:	U.S. Congressional Research.
Subjects:	Abortion. Family planning. Medical laws and legislation. Electronic books.
Online Access:	Connect to the full text of this electronic book

Description
Summary:	Describes background of FDA approval and conditions of use for the abortion drug mifepristone, also known as RU-486, and legislative issues that may include restrictions on program funding and drug use. Considers FDA approval of the drug in 2000 and potential impact of RU-486 use.
Item Description:	Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed July 2010). Reuse except for individual research requires license from ProQuest, LLC. CRS Report. Electronic resource.
Physical Description:	1 online resource.